| | Isolation of methicillin-resistant coagulase-negative staphylococci from patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and comparison of different molecular techniques for discriminating isolates of Staphylococcus epidermidisReceived 16 April 2002; accepted 19 August 2002. Abstract Coagulase-negative staphylococci (CNS) have emerged as an important pathogen in nosocomial infections. About 80%–90% of CNS isolates associated with hospital infections are methicillin-resistant coagulase-negative staphylococci (MRCNS). The aims of this study were to screen for MRCNS isolates in the flora of a small population of patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and to evaluate the discriminatory power of different molecular methods: pulsed-field gel electrophoresis (PFGE), mecA location, ClaI/mecA polymorphism and arbitrarely primed polymerase chain reaction (AP-PCR) for characterizing isolates of methicillin-resistant Staphyloccus epidermidis (MRSE). Seventy-nine CNS isolates were recovered from the 11 CAPD patients studied. Using a methicillin screening agar and a DNA specific mecA probe we verified that 30 of the 79 (38%) CNS isolates were resistant to methicillin (MRCNS). Twenty-two of the 30 MRCNS (73%) were MRSE, 7 (23%) methicillin-resistant S. haemolyticus (MRSHae) and 1 (3%) methicillin-resistant S. hominis (MRSHom). All patients analyzed carried MRCNS in their flora, in one or more sites. Since CAPD patients have high risk for developing peritonitis, the colonization of these patients with MRCNS might represent an adittional problem, due to the therapeutic restrictions imposed by these multiresistant isolates. A wide genetic diversity was verified when the PFGE of the MRSE isolates was analyzed. The 22 MRSE isolates displayed a total of 15 PFGE different patterns (11 PFGE types and 4 subtypes). The location of mecA in the SmaI-fragmented genome DNA did not bring any additional advantage for epidemiologic characterization of the isolates. The ClaI/mecA polymorphism was able to correctly discriminate 12 from the 15 PFGE patterns. In addition, the DNA of 20 MRSE isolates were used for AP-PCR typing. These isolates belonged to 14 PFGE patterns (11 types and 3 subtypes) and displayed 15 genotypes (for the association of PFGE, mecA location and ClaI/mecA polymorphism). A total of 17 different amplification patterns was verified using the primer 1. Only for 2 genotypes, strains having identical genetic backgrounds were further discriminated by AP-PCR (2 of 15 genotypes (87%) for AP-PCR and 1 of 15 genotypes for PFGE; (93%). Concluding, our results indicated that the AP-PCR can be an alternative and useful tool for monitoring and genotyping MRSE colonization and also to molecular characterizing MRSE outbreaks in hospitals.
1. Introduction  Although previously regarded as harmless commensal bacteria, the coagulase-negative staphylococci (CNS) areincreasing in importance as cause of hospital-acquired in-fections, generally associated with the use of medical devices in seriously ill and immunocompromised patients (Kloos & Bannerman, 1994). Staphylococcus epidermidis is the most frequently isolated species, among the CNS isolates, in bacteremia associated with indwelling catheters and other implanted devices. In contrast to Staphylococcus aureus, which are isolated from the nares of about 30% of healthy adults, CNS can be isolated from almost all healthy individuals (Hu et al., 1995). The spread of methicillin-resistant S. aureus (MRSA) and of CNS isolates are of great concern in hospitals and other health care settings. About 80%–90% of CNS isolated in hospitals (Raad et al., 1998) and 30%–40% of these isolates obtained from healthy carriers or patients from the community are methicillin-resistant coagulase-negative staphylococci (MRCNS; Silva et al., 2001). The mecA gene encoding methicillin resistance is widely disseminated among Staphylococcus species Archer and Niemeyer 1994, Pierre et al 1990. This widespread distribution of mecA might be due to horizontal transmissions among CNS isolates and S. aureus Archer and Niemeyer 1994, Archer and Scott 1991. Serious nosocomial infections caused by these methicillin-resistant staphylococci (MRS) frequently require administration of non β-lactam antibiotics and the options are currently quite limited. Glycopeptide antibiotics and the newly introduced drugs, such as streptogramins (quinupristin-dalfopristin) and oxazolidinones (linezolid) are the remaining effective therapies (Paradisi et al., 2001). An analysis of microbiologic trends in peritoneal dialysis-related peritonitis from 1991 to 1998, carried out in Canada, showed that S. epidermidis and S. aureus were the most common causes of peritonitis. These microorganisms were isolated in about 28% and 19% of the positive-culture cases, respectively (Zelenitsky et al., 2000). Epidemiologic evidences suggested that indigenous MRCNS were associated with about 8% of the peritonitis episodes (Dryden et al., 1992). A generally accepted typing scheme for S. epidermidis does not exist, however pulsed-field gel electrophoresis (PFGE) is becoming the standard method for molecular typing of many bacterial species (Bannerman et al., 1995). Despite of that, PFGE is a relatively expensive and laborious technique for using in clinical laboratories. The aims of this study were to screen for methicillin-resistance among CNS isolates in the microbial flora of 11 patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and to evaluate the discriminatory power of four different DNA methods for the molecular characterization of the MRSE isolates.
2. Materials and methods  2.1. Isolates CNS isolates were obtained from different sites: groin, nares, catheter and axilla of 11 CAPD patients attending a public hospital located in Rio de Janeiro City. The swabs were plated individually on trypticase soy agar (TSA) and the plates incubated at 37°C for 18–24 h. Five isolated colonies from each plate, with morphologic characteristics of staphylococci, were transferred to 5 individual tubes containing trypticase soy broth (TSB) and incubated for 18h at 37°C. Staphylococci were identified presumptively by Gram-stain and by free-coagulase and catalase tests. The Gram-positive, coagulase negative and catalase positive cultures were submitted to biochemistry identification using an Autoscan, Microscan System (Dade Behringer, Sacramento, USA). The strains were stored in TSB containing 10% glycerol (v/v) at −70°C. 2.2. Screening test for methicillin resistance This test was performed as described previously using TSA plates, containing 25 μg/mL methicillin (de Lencastre et al., 1991). After an incubation period of 24h to 48h at 35°C, any growth was taken as an indication of resistance. The methicillin-susceptible S. aureus (MSSA) strain ATCC 25923 and the methicillin-resistant S. aureus (MRSA) strain Col, obtained from Dr. Alexander Tomasz, from The Rockefeller University, NY, USA, were used as controls in this test. 2.3. Antibiotic susceptibility test The susceptibility test was carried out as recommended by the National Committee for Clinical Laboratory Standards (NCCLS, 1999). The disks used contained the following antibiotics: Pn, penicillin G (10 U), SxT, trimethoprim (1.25 μg) plus sulfamethoxazole (23.75 μg); Gn, gentamicin (10 μg); Tc, tetracycline (30 μg); Er, erytromycin (15 μg); Cl, clindamycin (2 μg); Co, chloramphenicol (30 μg). The strain ATCC 25923 was used for controlling the test. 2.4. DNA preparation All procedures for chromosomal or plasmid DNA preparations were carried out as described previously (Sambrook et al., 1989), except that bacterial cell lysis was achieved following pre-incubation of the cells with mutanolysin (103 U/ml), lysozime (7 × 103 U/ml) and Brij 35% (0,5% v/v) for 18 h at 37°C. 2.5. Pulsed-field gel electrophoresis The preparation of low-melting agarose inserted genomic DNA and the digestion with the restriction endonuclease SmaI was described previously (de Lencastre et al., 1994). Pulsed-field gel electrophoresis (PFGE) was performed in a CHEF-DRIII apparatus (BioRad), with a voltage of 5.5 V/cm, ramped with an initial forward time of 1s and a final forward time of 30s. Agarose DNA gels (1%; w/v) were run during 23h at 11°C, in 0.5× TBE (50 mM Tris buffer containing 50 mM boric acid and 0.2 mM EDTA, pH 8.0). Gel staining and photography were carried out as described previously (Sambrook et al., 1989). The DNA fragments were blotted on to nylon membranes (H-Hybond, Amersham) using a vacuum transfer system, as recommended by the manufacturer (Pharmacia). After that, the DNA was fixed by baking at 80°C for 2h, and hybridized with the mecA-DNA probe. The criteria for interpreting the PFGE patterns were described previously (Tenover et al., 1995). 2.6. mecA gene polymorphism The agarose inserted DNA was digested with the restriction endonuclease ClaI, as recommended by the manufacturer. The DNA fragments were separated by conventional electrophoresis using a 0.8% w/v agarose DNA gel (40V/18h) in TAE buffer. The procedures for Gel staining and photography were described previously (Sambrook et al., 1989). The DNA fragments blotted on to nylon membranes by vacuum were fixed by baking and hybridized with the mecA-DNA probe. 2.7. Preparation of the mecA DNA probe The fluorescein-labeled mecA DNA probe was the 1.196kb Pst1-Xba1 fragment (MF13) from the mecA gene of the Australian type strain ANS46, cloned in pTZ219 (Matthews, Reed & Stewart, 1987). The digested plasmid DNA was separated by 0.8% w/v agarose gel electrophoresis. The correspondent band was excised from and purified using the Sephaglas Bandprep Kit (Pharmacia). The fragment was labeled by chemiluminescence using the ECL Random Prime Labeling System (Amersham International), as recommended by the manufacturer. 2.8. Arbitrarily primed polymerize chain reaction (AP-PCR) The AP-PCR reaction was performed using 50 ng DNA, 0.2 mM dNTPs (Pharmacia), 2.5U Taq DNA polymerize (Pharmacia), 1× PCR buffer (Gibco, BRL), 2.5 mM MgCl2 (Pharmacia), 50 pmol primer 1 (5′-GGTTGGGTGAGAATTGCACG-3′); van Belkum et al., 1995a). Cycling was performed in Perkin Elmer machine (Gene Amp® PCR System 9700), as described by van Belkum et al., 1995a. To assure reproducibility, all PCR reactions were carried out in at least three independent PCR amplifications, using different DNA preparations but the same batch of PCR reactions. In addition, DNA of a strain tested in previous PCR experiments (having a known AP-PCR type) was also amplified with each set of PCR reactions, for controlling the amplification conditions. Also, only one person was responsible for carrying out all the procedures for the AP-PCR. Because most of the MRSE populations display a considerable large genetic diversity, to test the ability of the AP-PCR, using the primer 1, to identify as identical isolates having the same genetic background, we used the DNA of isolates belonging to a close related bacterial species, the S. aureus. Thus, we prepared genomic DNA from 10 well characterized MRSA isolates belonging to the Brazilian epidemic clone (BEC) displaying exactly the same genotype: PFGE type (A1), the same mecA location, ClaI/mecA polymorphism type (III), ClaI/Tn554 polymorphism type (B) and the same insertion pattern for the IS257 (Teixeira et al., 1995). The criterion of one-band difference was used to discriminate the AP-PCR patterns. Differences due to band intensity and thickness were not taking in consideration.
3. Results  3.1. Bacterial identification Seventy-nine CNS isolates were recovered from groin, nares, axilla or catheter of the 11 CAPD patients studied. Thirty isolates of the 79 CNS strains (38%) were methicillin-resistant. The identification of the MRCNS isolates showed that 22 (73%) were MRSE, 7 (23%) methicillin-resistant S. haemolyticus (MRSHae) and one (3%) methicillin-resistant S. hominis (MRSHom). All patients analyzed carried MRCNS in their flora (Table 1). | | |  | Strain | Specie | Patient | Site | PFGE pattern | mecA location(Kb)/PFGE band | ClaI/mecA polymorphism | |  |
 | BMB15UR | S. epidermidis | 1 | groin | B | 253/c | 2 | Pn, Tc, Er |  |
 | BMB43UR | S. epidermidis | 1 | axilla | B1 | 260/c | 3 | Pn, Tc |  |
 | BMB31UR | S. epidermidis | 3 | groin | D | 73/e | 5 | Pn, Er, Gn, Sxt |  |
 | BMB41UR | S. epidermidis | 4 | groin | E | 231/e | 6 | Pn, Gn, Sxt |  |
 | BMB42UR | S. epidermidis | 4 | groin | E | 231/e | 7 | Pn, Gn, Sxt |  |
 | BMB63UR | S. epidermidis | 4 | groin | E | 231/e | 7 | Pn, Tc, Gn, Sxt |  |
 | BMB64UR | S. epidermidis | 4 | groin | E1 | 233/e | 6 | Pn, Er |  |
 | BMB73UR | S. epidermidis | 4 | axilla | E2 | 231/e | 7 | Pn, Gn, Sxt |  |
 | BMB48UR | S. epidermidis | 5 | axilla | F | 301/c | 8 | Pn, Gn, Sxt |  |
 | BMB55UR | S. epidermidis | 5 | catheter | F | 301/c | 8 | Pn, Tc, Sxt |  |
 | BMB59UR | S. epidermidis | 6 | groin | G | 348/b | 9 | Pn |  |
 | BMB62UR | S. epidermidis | 6 | axilla | H | 159/e | 10 | Pn, Sxt, Co |  |
 | BMB65UR | S. epidermidis | 8 | ND | J | 358/b | 9 | Pn, Gn, Sxt |  |
 | BMB68UR | S. epidermidis | 8 | ND | J | 358/b | 9 | Pn, Er, Gn, Sxt |  |
 | BMB69UR | S. epidermidis | 8 | ND | J1 | 368/a | 13 | Pn, Gn, Sxt |  |
 | BMB76UR | S. epidermidis | 9 | groin | L | 88/h | 14 | Pn, Gn |  |
 | BMB77UR | S. epidermidis | 9 | axilla | L | 88/h | 14 | Pn, Gn |  |
 | BMB78UR | S. epidermidis | 10 | axilla | M | 877/a/r | 15 | Pn, Gn, Sxt |  |
 | BMB82UR | S. epidermidis | 10 | groin | N | 77/l | 9 | Pn, Gn, Sxt |  |
 | BMB86UR | S. epidermidis | 11 | axilla | P | 62/o | 17 | Pn, Sxt |  |
 | BMB87UR | S. epidermidis | 11 | groin | P | 62/o | 17 | Pn, Sxt |  |
 | BMB88UR | S. epidermidis | 11 | nose | P | 62/o | 17 | Pn |  |
 | BMB12UR | S. haemolyticus | 1 | catheter | A | 193/e | 1 | Pn, Tc, Gn, Sxt, Co |  |
 | BMB13UR | S. haemolyticus | 1 | axilla | A | 193/e | 1 | Pn, Tc |  |
 | BMB30UR | S. haemolyticus | 2 | groin | C | 10/e | 4 | Pn, Er, Gn, Sxt |  |
 | BMB60UR | S. haemolyticus | 7 | nose | I | 170/e | 11 | Pn, Gn, Tc, Er, Sxt, Co, Cp, Cl |  |
 | BMB61UR | S. haemolyticus | 7 | groin | I1 | 181/e | 11 | Pn, Tc, Er, Co, Cp, Cl |  |
 | BMB83UR | S. haemolyticus | 11 | nose | O | 18/j | 16 | Pn, Tc, Sxt |  |
 | BMB84UR | S. haemolyticus | 11 | nose | O | 18/j | 16 | Pn, Tc, Gn, Sxt |  |
 | BMB67UR | S. hominis | 8 | ND | K | 225/d | 12 | Pn, Tc |  | | | |
|
a
Antibiotype means antimicrobial resistant pattern for Pn, penicillin G (10 U); SxT, trimethoprim (1.25 μg) plus sulphamethoxazole (23.75 μg); Gn, gentamicin (10 μg); Tc, tetracycline (30 μg); Er, erytromycin (15 μg); Cl, clindamycin (2 μg); Co, chloramphenicol (30 μg). |
3.2. Antibiotic susceptibility Besides being resistant to β-lactam antibiotics, 15 of the 22 MRSE isolates tested were also resistant to trimethoprim-sulfamethoxazole, 13 to gentamicin, 4 to tetracycline, 4 to erytromycin and 1 to chloramphenicol. Among the 7 MRSHae obtained, 5 were resistant to trimethoprim-sulfamethoxazole, 4 to gentamicin, 6 to tetracycline, 3 to erythromycin, 3 to chloramphenicol and 2 to clindamycin. The unique MRSHom isolate, in addition to β-lactam resistance, was resistant only to tetracycline (Table 1). 3.3. Methicillin resistant It was observed that no borderline or susceptible isolate grew on plates containing methicillin at concentration of 25 μg/ml. Any growth was taken as an indication of methicillin resistance and examined further by using a mecA-specific DNA probe. There was a 100% agreement between growth on screen agar plates and the mecA probe. 3.4. PFGE analysis After restriction of the genomic DNA with SmaI, PFGE resolved the 22 MRSE isolates into 11 PFGE types (B, D, E, F, G, H, J, L, M, N, and P; Table 1). The pattern B had one subtype, assigned B1, that had 2 band differences from B. Another pattern designed as E also had 2 subtypes (E1 and E2), differing in 4 bands each from pattern E. Finally, the pattern J had um subtype (J1) that differed in 2 bands (Fig. 1A,B). Among the 7 MRSHae, 4 major patterns were observed (A, C, I and O). The pattern assigned I had one subtypes (I1) differing by 2 PFGE bands. The only strain of MRSHom displayed a pattern called K. All variants of a specific type (subtypes) were isolated from a same patient. Strains of MRSE or MRSHae, showing the same or related genetic background, have not been detected colonizing different patients. 3.5. mecA location When the SmaI fragments were transferred to a nylon membrane and hybridized with the mecA DNA probe, different patterns of hibridization were observed. Strains of MRSE or MRSHae displaying exactly the same PFGE patterns had the mecA gene located at the same PFGE fragment size and PFGE band (Table 1). In addition, isolates displaying different PFGE patterns had different SmaI/mecA polymorphisms, except for the MRSE isolate displaying subtype E2, that has the same mecA location observed for type E strains. It is interesting that all MRSE subtypes (except for subtype E2) and MRSHae subtypes I and I1 had mutations in the mecA gene or in its vicinity affecting the SmaI restriction site. Thus, the MRSE subtype B1 had the mecA gene inserted in a fragment size of 260 kb in the PFGE band “c” while pattern B had the mecA gene inserted in a fragment size of 253 kb in the band “c.” In the same way, MRSE subtype E1 had the mecA gene located in a fragment of 233 kb in the band “e” while pattern E had the mecA gene in a fragment of 231 kb in the band “e.” The same was observed for the MRSE subtype J1, in which the mecA gene was inserted in a fragment of 368 kb in the band “b” while the pattern J had the mecA in the band “b” of 358 kb. Finally, for the MRSHae subtype I1, the mecA was in a PFGE fragment of 181 kb in the band “e” while the mecA gene in the PFGE pattern I was located also in the band “e” but in a fragment of 170kb (Table 1). 3.6. ClaI/mecA polymorphism The chromosomal vicinity of the mecA gene in the isolates was also investigated with a DNA probe internal to the mecA gene, after ClaI restriction and conventional DNA gel electrophoresis (Table 1). Twelve ClaI/mecA polymorphisms were obtained among the 22 MRSE strains displaying 15 different PFGE patterns. However, strains belonged to PFGE pattern E displayed two different ClaI/mecA polymorphisms 6 and 7. The contrary was also observed, the same ClaI/mecA polymorphism type 9 was verified among MRSE strains belonging to three different PFGE patterns (G, J and N). Concerned to the PFGE subtypes, a different ClaI/mecA polymorphism was verified for B and B1 variants (ClaI/mecA types 2 and 3; respectively), for J and J1 (ClaI/mecA types 9 and 13, respectively) and finally for E1 and E2 (ClaI/mecA types 6 and 7). The 7 MRSHae studied were classified in 4 ClaI/mecA polymorphisms (Table 1). However, the MRSHae isolates displaying subtype I1 had the same ClaI/mecA polymorphism of the isolate displaying PFGE pattern I (type 11; Table 1). 3.7. AP-PCR All ten BEC isolates used as control of the PCR reproducibility, displaying the same genotype, had exactly the same and reproducible AP-PCR pattern (Fig. 2). The DNA of 20 MRSE isolates used for AP-PCR corresponded to 14 PFGE different patterns (11 PFGE types and 3 subtypes). Seventeen different amplification patterns were verified using the primer 1 (Fig. 3). Each PFGE pattern corresponded to only one AP-PCR type, except for 3 strains from pattern E, that displayed different AP-PCR types (strain BMB41UR, AP-PCR type III; BMB42UR, type IV and BMB63UR, type V) and 2 strains from PFGE pattern P, that displayed AP-PCR pattern XVI (BMB86UR) and pattern XVII (BMB87UR; Table 2). In relation to the subtypes analyzed, the pattern B isolate could be discriminated from the subtype B1, the pattern E from the subtype E2 and so as the pattern J from the subtype J1 (Table 2). |
a
Strains of genotypes 5 and 15 had 2 different AP-PCR types each.
b
The same genotype was displayed by two different isolates. |
The 20 MRSE analyzed was discriminated in 15 genotypes when 3 of the molecular techniques used in this study were associated (PFGE, mecA location and ClaI/mecA polymorphism). In only two cases (for genotypes 5 and 15), the AP-PCR discriminated isolates of the same genotype in different amplification patterns (Table 2). However, if the antibiotype (antibiotic resistance pattern) was also associated to the genotype, the two isolates (BMB42UR and BMB63UR) displaying genotype 5 (E/231e/7) could be further discriminated in antibiotypes Pn/Gn/Sxt and Pn/Tc/Gn/Sxt. However, we did not find any difference that justified the discrimination by the AP-PCR of the strains BMB86UR and MBM87UR; presenting both genotype 15 (P/62o/17) and antibiotype Pn/Sxt.
4. Discussion  During the last decades, changing trends in the practice and progress of medicine resulted in the emergence of CNS isolates as a major cause of nosocomial bacteremia Mickelsen et al 1985, Tuazon and Miller 1983, Raad and Bodey 1992, Jones 1996. Given the excessive use of antibiotics, multidrug-resistant coagulase-negative staphylococci have emerged, including methicillin-resistant isolates. MRSE are cross resistant to all β-lactam antibiotics, even though some isolates might be susceptible to certain β-lactam agents by in vitro testing (Lowy et al., 1982). Therefore, the resistance profile of MRCNS isolates is very similar to that of MRSA. Antimicrobial resistance is also recognized as a substantial problem for a number of community-acquired infectious diseases caused by CNS. Silva et al. (2001) have recently shown that a quarter of healthy individuals from three different communities in Rio de Janeiro city harbored MRCNS in the nose. In recent years, decreased susceptibility to glycopeptides among CNS, including S. epidermidis, has been reported in hospitals Cercenado et al 1996, Jeljaszewicz et al 1998, Silva et al 2001. It was suggested that skin colonization with CNS followed by access to the peritoneum via catheters is a probable route of infection (West et al., 1986). In this paper, we isolated 30 MRCNS from the 11 CAPD patients. All patients carried MRCNS in at least one site. Since CAPD patients have high risk for developing peritonitis, the colonization of these patients with MRCNS might represent an additional problem, due to the therapeutic restrictions. The incidence of MRCNS among the patients studied was higher than the 30% expected for healthy populations (Silva et al., 2001), which is consistent with the frequent circulation of these patients in hospital settings, increasing the risk of colonization by resistant isolates. Several molecular typing methods have been demonstrated to be valuable for discriminating bacterial isolates. Frequently, PFGE is referred to be the most acceptable molecular technique for characterizing bacterial clones (Calderwood et al., 1996). Using PFGE we verified a considerable genome diversity among the S. epidermidis isolates collected from CAPD patients. Eleven different PFGE clone types and 4 subtypes were obtained from the 22 S. epidermidis isolates studied. In addition to PFGE, genetic diversity was also verified by using SmaI/mecA polymorphism or AP-PCR. In a previous study, we suggested that the wide genomic diversity among the MRSE flora of healthy humans were probably due to the horizontal transmission of the mecA gene among the isolates, what seemed to be the major mechanism of methicillin resistance spread among the MRSE flora in the community (Silva et al., 2001). Furthermore, it was shown by others that a considerable number of patients experienced bacteremic episodes in hospitals were caused by CNS isolates belonging to different genotypes, as showed the analysis of PFGE and AP-PCR techniques (van Belkum et al., 1996). Regardless of the limited number of MRSE and MRSHae isolates studied, it is interesting to remark that strains from the same PFGE clonal type or subtypes could be verified colonizing different sites of a patient. In only two patients, clones having different genetic backgrounds were isolated colonizing different sites of a same person. In addition, despite the genetic diversity, the stability of the carriage state was verified for patient 4, from whom samples monthly collected, during a period of 4 months, had the same clone type E of MRSE. These results and the high incidence of MRSE among the CAPD patients analyzed tempted us to suggest that the MRSE flora seems to be more representative of a resident than a transitory colonization. Similar results were obtained by others that showed certain strains of MRSE appeared to be permanent colonizers of a hospital hematology ward or ward-related personnel. Indeed, in individual patients, persistent colonization by a single type was also demonstrated (van Belkum et al., 1996). The analysis of the location of mecA gene showed that all MRSE subtypes, except one (subtype E2), had at least one genetic event involving the mec region or its vicinity, indicating the occurrence of genomic insertion, deletion or recombination in this region involving the SmaI sites. These genetic events in the mec region were confirmed by the fragmentation of the MRSE genome with another enzyme, the endonuclease ClaI, indicating that these changes did not involve the SmaI sites only. Even for the strain displaying E1 subtype, that showed a SmaI/mecA band of 233kb, its tiny difference from the SmaI/mecA band of 231 kb of type E isolate was confirmed by ClaI-fragmentation of the bacterial genome, since these isolates showed also a different ClaI/mecA hibridization patterns. Similarly, Dominguez et al. (1996) verified that, in contrast to S. aureus that has a relatively limited set of ClaI/mecA polymorphism, the SCN isolates studied that had 14 different PFGE patterns displayed also 14 different mecA/ClaI hybridization patterns. Ito et al. (2001) verified that the β-lactam resistance gene mecA is carried by a novel genetic element, the staphylococcal cassette chromosome mec (SCCmec), identified in the chromosome of a Japanese (MRSA) strain MU50 and in all other methicillin-resistant Staphylococcus species so far analyzed. This element can precisely excised by mediation of cctA and ccrB (the cassette chromossoma recombinase genes) that encodes two specific recombinases, involved in recombination events (integration and excision). It was suggested that the mecA gene is transferred from cell to cell as a part of the SSCmec across the staphylococcal species (Katayama et al., 2000). Besides, the mec region of MRSE has an IS1272 element generally downstream of the truncated mecR1 gene (Kobayashi et al., 1999) that may contribute for some genetic instability in this region. Moreover, the mec region harbors a slightly polymorphic element, the dru (direct repeat unit) segment, which in an early S. aureus strain, BB270, was found to contain 10 imperfect 40 base-pair repeats. Strains of S. aureus or S. epidermidis can differed in numbers of repeats and/or sequences of particular repeats (Nahvi et al., 2001). Thus, the genetic characteristics of the SCCmec of S. epidermidis may explain the variability observed in the restriction fragment length polymorphism (RFLP) of these regions. The ClaI/mecA polymorphism was able to correctly discriminate 9 from 15 PFGE patterns among the total MRSE isolates (80%). Dominguez et al. (1996) using PFGE, mecA location and ClaI/mecA polymorphism, to analyze the molecular epidemiology of CNS isolates, suggested that these molecular techniques provided useful support in determining the transmission of CNS hospital diseases. However, our results showed that the location of mecA gene (SmaI/mecA polymorphism) in the MRCNS genome did not bring additional information to the PFGE that justified its use for epidemiologic studies. Additionally, we verified that, for the isolates of MRSE studied, the ClaI/mecA polymorphism was less discriminative than PFGE and AP-PCR. On the other hand, the results obtained with AP-PCR and PFGE were more comparable, since 9 of the 11 PFGE types displayed by the MRSE isolates had only one AP-PCR amplification pattern. In few cases, as also showed by van Belkum et al. (1995a), a comparison of AP-PCR with PFGE indicated the occurrence of isolates with constant PFGE types but variable AP-PCR types. For instance, the 3 type E MRSE isolates displayed different AP-PCR patterns: III, IV and V, However, 2 of the 3 E isolates could also be further discriminated in ClaI/mecA polymorphisms 6 and 7; what supports the AP-PCR discrimination of these two isolates in two different types. The other exception was for the isolates belonging to PFGE pattern P. The two isolates (BMB86UR and BMB87UR) had identical genotypes when all the molecular techniques were combined but AP-PCR types XVI and XVII. Thus, the discriminatory ability of the AP-PCR was slightly higher than that of PFGE. All the 3 PFGE subtypes analyzed: B1, J1 and E2, could be discriminated by AP-PCR from types B, J and E of MRSE, respectively. It is interesting to remark that B1, J1 and E2 variants were also discriminated from B, J and E isolates by ClaI/mecA polymorphism, and thus classified in different genotypes. Although the reproducibility of PFGE is well known to be higher than AP-PCR, due to technical factors associated with this technique (van Belkum et al., 1995b), the AP-PCR has apparently some advantages because it does not require restriction enzyme digestions and by the fact that thermocycler is already installed in many clinical laboratories. Also, the AP-PCR reproducibility problems can be overcome when the same batch of PCR reagents are used (van Belkum et al., 1995a). Whereas, AP-PCR showed to have poor reproducibility when comparison among AP-PCR types of the same strains were carried out in different institutions (van Belkum et al., 1995a). Concluding, our data indicated that AP-PCR could be an alternative and useful tool for monitoring and genotyping MRSE colonization and also to molecular characterizing MRSE outbreaks in a hospital, since controls are added to assure reproducibility of the method. Acknowledgements  This study was supported in part by grants from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Ministério da Saúde do Brasil, Fundação de Apoio à Pesquisa do Estado do Rio de Janeiro (FAPERJ) and FINEP/Pronex to A.M.S.F., B.T.F.C. and L.A.T. References  Archer and Niemeyer 1994.
1.
Archer GL, Niemeyer DM.
Origin and evolution of DNA associated with resistance to methicillin in staphylococci.
Trends Microbiol. 1994;2:325–347. Archer and Scott 1991.
2.
Archer GL, Scott J.
Conjugative transfer genes in staphylcoccal isolates from United States.
Antimicrob Agents Chemother. 1991;35:2500–2504. MEDLINE Bannerman et al 1995.
3.
Bannerman TL, Hancock GA, Tenover FC, Miller JM.
Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus.
J Clin Microbiol. 1995;33:551–555. MEDLINE Calderwood et al 1996.
4.
Calderwood SB, Baker MA, Carroll PA, Michel JL, Arbeit RD, Ausubel FM.
Use of cleaved amplified polymorphic sequences to distinguish strains of Staphylococcus epidermidis.
J Clin Microbiol. 1996;34:2860–2865. MEDLINE Cercenado et al 1996.
5.
Cercenado E, Garcia-Leoni ME, Diaz MD, Sánchez-Carrillo C, Catalán P, Quiros JCLB, et al.
Emergence of teicoplanin-resistant coagulase-negative sthaphylococci.
J Clin Microbiol. 1996;34:1765–1768. MEDLINE De Lencastre et al 1994.
6.
De Lencastre H, Couto I, Santos I, Melo-Cristino J, Torres-Pereira A, Tomasz A.
Methicillin-resistant Staphylococcus aureus in a Portuguese hospital (characterization of clone types by a combination of DNA typing methods).
Eur J Clin Microbiol Infect Dis. 1994;13:64–73. MEDLINE |
CrossRef
De Lencastre et al 1991.
7.
De Lencastre H, Figueiredo AMS, Urban C, Rahal J, Tomasz A.
Multiple mechanisms of methicillin resistance and improved methods for detection of clinical isolates of Staphylococcus aureus.
Antimicrob Agents Chemother. 1991;35:632–639. MEDLINE Dominguez et al 1996.
8.
Dominguez MA, Iinares J, Pulido A, Perez JL, De Lencastre H.
Molecular tracking of coagulase-negative staphylococcal isolates from catheter-related infections.
Microb Drug Resist. 1996;2:423–439. MEDLINE |
CrossRef
Dryden et al 1992.
9.
Dryden MS, Talsania H, McCann M, Cookson BD, Phillips I.
Epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients.
Epidemiol Infect. 1992;109:97–112. MEDLINE Hu et al 1995.
10.
Hu L, Umeca A, Amako K.
Typing of Staphylococcus epidermidis colonizing human nares by pulsed-field gel electrophoresis.
Microbiol Immunol. 1995;39:315–319. MEDLINE Ito et al 2001.
11.
Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, et al.
Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2001;45:1323–1336. MEDLINE |
CrossRef
Jeljaszewicz et al 1998.
12.
Jeljaszewicz J, Mlynarezyk G, Mlynarezyk A.
Present and future problems of antibiotic resistance in gram-positive cocci.
Infection. 1998;26:1–10. MEDLINE |
CrossRef
Jones 1996.
13.
Jones RN.
Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalizes patients.
Am J Med. 1996;100(Suppl 6A):3S–12S. Abstract |
Full-Text PDF (1240 KB)
|
CrossRef
Katayama et al 2000.
14.
Katayama Y, Ito T, Kiramatsu K.
A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 2000;44:1549–1555. MEDLINE |
CrossRef
Kloos and Bannerman 1994.
15.
Kloos WE, Bannerman TL.
Update on clinical significance of coagulase-negative staphylococci.
Clin Microbial Rev. 1994;7:117–140. Kobayashi et al 1999.
16.
Kobayashi, N., Vrasawa, S., Vehara N., & Watanabe N. (1999). Distribution of insertion sequence-like element IS1272 and its position relative to methicillin resistance genes in clinically important staphylococci. Antimicrob Agents Chemother, 43, 2780–2782. Lowy et al 1982.
17.
Lowy FD, Wexler WA, Steigbigel NH.
Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
J Lab Clin Med. 1982;100:94–104. MEDLINE Matthews et al 1987.
18.
Matthews PR, Reed KC, Stewart PR.
The cloning of chromossomal DNA associated with methicillin and other resistances in Staphylococcus aureus.
J Gen Microbiol. 1987;133:1919–1929. MEDLINE Mickelsen et al 1985.
19.
Mickelsen PA, Plorde JJ, Gordon KP, Hargiss C, McClure J, Schoenkneckt FD, et al.
Instability of antibiotic resistance in a strain of Staphylococcus epidermidis isolated from an outbreak of prosthetic valve endocarditis.
J Infect Dis. 1985;152:50–58. MEDLINE National Committee for Clinical Laboratory Standards 1998.
20.
National Committee for Clinical Laboratory Standards. (1998) Performance standards for antimicrobiol disk susceptibility test. Aproved standard M2-T4. Villanova, PA Nahvi et al 2001.
21.
Nahvi MD, Fitzgibbon JE, John JF, Dubin DT.
Sequence analysis of dru regions from methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates.
Microb Drug Resist. 2001;7:1–12. MEDLINE Paradisi et al 2001.
22.
Paradisi F, Corti G, Messeri D.
Antistaphylocccal (MSSA, MRAS, MSSE, MRSE) antibiotics.
Med Clin North Am. 2001;85:1–17. Abstract | Full Text |
Full-Text PDF (1056 KB)
|
CrossRef
Pierre et al 1990.
23.
Pierre J, Williamson R, Bornet M, Gutmann L.
Presence of an additional penicillin-binding protein in methicillin-resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus homonis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandole.
Antimicrob Agents Chemother. 1990;34:1691–1694. MEDLINE Raad et al 1998.
24.
Raad I, Alrahwan A, Rolston K.
Staphylococcus epidermidis (Emerging resistance and the need for alternative agents).
Clin Infect Dis. 1998;26:1182–1187. MEDLINE Raad and Bodey 1992.
25.
Raad II, Bodey GP.
Infectious complications of indewelling vascular catheters.
Clin Infect Dis. 1992;15:197–210. MEDLINE Sambrook et al 1989.
26.
Sambrook J, Fritsch EF, Maniatis T.
Molecular cloning (A laboratory manual). 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989;. Silva et al 2001.
27.
Silva FR, Mattos EM, Coimbra MVS, Ferreira-Carvalho BT, Figueiredo AMS.
Isolation and molecular characterization of methicillin-resistant coagulase-negative staphylococci from nasal flora of healthy humans at three community institutions in Rio de Janeiro City.
Epidemiol Infect. 2001;127:57–62. MEDLINE Teixeira et al 1995.
28.
Teixeira LA, Resenda CAFR, Ormonde LR, De Lencastre H, Figueiredo AMS, Tomasz A.
Geographic spread of an epidemic multiresistant Staphylcoccus aureus clone in Brazil.
J Clin Microbiol. 1995;9:2400–2404. Tenover et al 1995.
29.
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al.
Interpreting chromosomal DNA restriction patterns produced by Pulsed-Field Gel Electrophoresis (Criteria for bacterial strain typing).
J Clin Microbiol. 1995;33:2233–2239. MEDLINE Tuazon and Miller 1983.
30.
Tuazon CU, Miller H.
Clinical and microbiological aspects of serious infections caused by Staphylococcus epidermidis.
Scand J Infect Dis. 1983;15:347–360. MEDLINE van Belkum et al 1995a.
31.
van Belkum AV, Kluijtmans J, Leeuwen WV, Bax R, Quint W, Peters E, et al.
Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains.
J Clin Microbiol. 1995;33:1537–1547. MEDLINE van Belkum et al 1995b.
32.
van Belkum AV, Kluijtmans J, Leeuwen WV, Goessens W, ter Averst E, Verbrugh H.
Investigation into the repeated recovery of coagulase-negative staphylococci from blood taken at the end of cardiopulmonary by-pass.
J Hosp Infect. 1995;31:285–293. Abstract |
Full-Text PDF (870 KB)
|
CrossRef
van Belkum et al 1996.
33.
van Belkum AV, Kluijtmans J, Leeuwen WV, Goessens W, ter Averst E, Wielenga J, et al.
Monitoring persistence of coagulase-negative staphylococci in a hematology department using phenotypic and genotypic strategies.
Infect Control Hosp Epidemiol. 1996;17:660–671. West et al 1986.
34.
West TE, Walsh JJ, Krol CP, Amsterdam D.
Staphylococcal peritonitis in patients on continuous peritoneal dialysis.
J Clin Microbiol. 1986;23:809–812. MEDLINE Zelenitsky et al 2000.
35.
Zelenitsky S, Barns L, Findalay I, Alfa M, Ariano R, Fine A, et al.
Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998.
Am J Kidney Dis. 2000;36:1009–1013. Abstract |
Full-Text PDF (72 KB)
|
CrossRef
a Laboratório de Biologia Molecular de Bactérias, Instituto de Microbiologia Prof. Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil b Laboratório de Tecnologia de Produtos Naturais, Faculdde de Farmácia, Universidade Federal Fluminense, Rio de Janeiro, Brazil c Hospital das Forças Aéreas do Galeão, Rio de Janeiro, Brazil Corresponding author. Tel.: +021-2260-4193; fax: +021-2560-8028.
PII: S0732-8893(02)00477-7 doi:10.1016/S0732-8893(02)00477-7 © 2003 Elsevier Science Inc. All rights reserved. | |
|